BIOV — BioVersys AG Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall Cap

Annual balance sheet for BioVersys AG, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.

	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—
Source:	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS
Status:	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	28.4	32.6	82.5
Net Total Receivables	2.06	1.29	2.44
Prepaid Expenses
Total Other Current Assets
Total Current Assets	33.6	34.4	89.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.581	0.558	0.765
Total Assets	34.2	35	90.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.37	9.67	8.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	25.6	24.3	30.8
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	8.58	10.7	59.8
Total Liabilities & Shareholders' Equity	34.2	35	90.6
Total Common Shares Outstanding